The dual amylin and calcitonin receptor agonist KBP-336 elicits a unique combination of weight loss, antinociception and bone protection – a novel disease-modifying osteoarthritis drug
K. Mohamed, A. T. Larsen, S. Melander, F. Andersen, Ellen Barendorff Kerrn, M. A. Karsdal, Kim Henriksen
Arthritis Research & Therapy